Effect of Family and Personal Medical History on Treatment Outcomes of Tyrosine Kinase Inhibitors (TKIs) in Non-Small Cell Lung Cancer (NSCLC).

Healthcare (Basel) · 2025 · PMC12346163 · PMID 40805843

Europe PMC DOI

hedged sentence

0.0520

closest p · 1.0× alpha

0.0520

boldest claim

The sentences

approached significancep = 0.052so close (0.05 < p ≤ 0.1)

The association with poor ECOG performance (≥3) approached significance ( p = 0.052). 4.

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.